Cell line and drug

Publication Title Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth
DOI https://doi.org/10.1016/j.bcp.2015.10.015
Year 2015
 
 
Please select
 
 
miRNA ID
Trait, Trait subtype
Cell Line
Drug 1
Drug 2
Drug 3
  
MI0000268 Osteosarcoma (OS), "" Parent MG-63 Doxorubicin Not Applicable Not Applicable
MI0000268 Osteosarcoma (OS), "" Parent 143B Doxorubicin Not Applicable Not Applicable
Count 2